Recent News

  • Medicare coverage for testing ends June 22After June 21, Medicare will limit coverage for the core drug-sensitivity genetic tests that comprise YouScript’s Polypharmacy test panel. This means that if you or a loved one are 65 or older and not taking the drugs Plavix, nortriptyline, amitriptyline or Xenazine, you will lose this Medicare benefit.  Drug-sensitivity testing, also ...Read More
  • Genelex research awarded at managed care pharmacy conferenceRecent research undertaken by Genelex has been recognized at the national Academy of Managed Care Pharmacy (AMCP) conference. The research shows that as many as 50 percent of patients 65 and older are taking at least one medication metabolized by a genetically variable drug metabolizing enzyme. The poster for this ...Read More